应急响应中使用埃博拉疫苗的考量
本文综述埃博拉病毒病疫苗在疫情应急响应中的使用考量,整合传统防控措施。2014—2016年西非疫情加速了疫苗临床试验,几内亚、利比里亚和塞拉利昂积累了紧急环状疫苗接种经验。各国需评估疫情风险、疫苗可及性与实施能力等因素,考虑环状接种、医护人员接种和群体接种等策略。
要点
- 埃博拉疫苗接种可限制疾病传播和死亡,应整合于传统疫情防控制度。
- 即便疫苗未获批,高风险国家可考虑为医护人员和一线人员等高风险群体接种。
- 应急接种策略包括环状或地理靶向社区接种、医护人员接种和群体接种。
核心结论
- 埃博拉疫苗接种是未来疫情中限制传播和死亡的工具,应整合于传统埃博拉疫情防控措施。
研究设计与样本
- 本文为综述,概述埃博拉流行病学、免疫学及支持应急响应中使用疫苗的证据。
主要发现
- 2014—2016年西非埃博拉疫情加速了埃博拉疫苗临床试验。
- 几内亚、利比里亚和塞拉利昂的公共卫生当局获得了实施紧急环状疫苗接种的经验。
- 支持疫情期间使用埃博拉疫苗的证据已出现,高风险国家正考虑如何将疫苗纳入未来应急响应及高风险群体预防。
关键数值与推荐
- 计划使用疫苗的国家或地区需评估未来埃博拉疫情发生的可能性。
- 需评估最可能引起疫情的病毒种属。
- 需评估受影响人群获得安全有效疫苗(未获批或已获批)的可能性。
- 需评估结合标准疫情控制措施实施埃博拉疫苗接种的能力。
- 需评估实施紧急埃博拉疫苗接种的最低必要资源和监管要求是否具备。
临床怎么用
- 作者提出可考虑的潜在应急接种策略包括环状或地理靶向社区接种、医护人员和一线人员接种以及群体接种。
- 制定埃博拉疫苗接种指南和方案有助于确保活动标准化、循证并与整体疫情响应协调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination against Ebola virus disease is a tool that may limit disease transmission and deaths in future outbreaks, integrated within traditional Ebola outbreak prevention and control measures. Although a licensed Ebolavirus vaccine (EV) is not yet available, the 2014-2016 West African Ebola outbreak has accelerated EV clinical trials and given public health authorities in Guinea, Liberia, and Sierra Leone experience with implementation of emergency ring vaccination. As evidence supporting the use of EV during an outbreak response has become available, public health authorities in at-risk countries are considering how to integrate EV into future emergency Ebola responses and for prevention in high-risk groups, such as healthcare workers and frontline workers (HCW/FLWs), even before an EV is licensed. This review provides an overview of Ebola epidemiology, immunology, and evidence to inform regional and country-level decisions regarding EV delivery during an emergency response and to at-risk populations before a licensed vaccine is available and beyond. Countries or regions planning to use EV will need to assess factors such as the likelihood of a future Ebolavirus outbreak, the most likely species to cause an outbreak, the availability of a safe and effective EV (unlicensed or licensed) for the affected population, capacity to implement Ebola vaccination in conjunction with standard Ebola outbreak control measures, and availability of minimum essential resources and regulatory requirements to implement emergency Ebola vaccination. Potential emergency vaccination strategies for consideration include ring or geographically targeted community vaccination, HCW/FLW vaccination, and mass vaccination. The development of guidelines and protocols for Ebola vaccination will help ensure that activities are standardized, evidence-based, and well-coordinated with overall Ebola outbreak response efforts in the future.
引用
- Walldorf JA, Cloessner EA, Hyde TB, et al. Considerations for use of Ebola vaccine during an emergency response. Vaccine. 2017. PMID: 28890191. doi:10.1016/j.vaccine.2017.08.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。